New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Champions Oncology, Inc.
CSBR
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

152M

Biotechnology

Next Earning date - 11 Mar 2025

152M

Biotechnology

Next Earning date - 11 Mar 2025

11.00USD

Shape0.34 ( 3.19%)
Market Closed (as of Feb 08, 00:38 EDT)
favorite-chart

Relative Strenght

98
favorite-chart

Volume Buzz

-25%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

8%

Quote Panel

Shape
Updated February 9, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

CSBR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$56M

Shape316%

2025-Revenue

$0.21

Shape292%

2025-EPS

$1M

Shape-207%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Craig-Hallum

upgrade

Previous: Not converted

2024-09-12

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.18
vs 0.05

Q2.23

arrow
arrow

N/A

-0.19
vs -0.03

Q3.23

arrow
arrow

N/A

-0.19
vs -0.02

Q4.23

arrow
arrow

N/A

-0.15
vs -0.00

Q1.24

arrow
arrow

N/A

-0.19
vs -0.18

Q2.24

arrow
arrow

N/A

-0.01
vs -0.19

Q3.24

arrow
arrow

+158%

0.11
vs -0.19

Q4.24

arrow
arrow

+133%

0.05
vs -0.15

Q1.25

arrow
arrow

N/A

-0.01
vs -0.19

Q2.25

arrow
arrow

+700%

0.06
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-3%

12.8M  vs 13.2M

Q2.23

arrow
arrow

+2%

13.1M  vs 12.9M

Q3.23

arrow
arrow

-9%

12.6M  vs 13.7M

Q4.23

arrow
arrow

-19%

11.6M  vs 14.3M

Q1.24

arrow
arrow

-6%

12M  vs 12.8M

Q2.24

arrow
arrow

+7%

14M  vs 13.1M

Q3.24

arrow
arrow

+12%

14.1M  vs 12.6M

Q4.24

arrow
arrow

+17%

13.5M  vs 11.6M

Q1.25

arrow
arrow

+7%

12.9M  vs 12M

Q2.25

arrow
arrow

+12%

15.7M  vs 14M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-35%

-0.35
vs -0.00

Q2.23

arrow
arrow

-55%

-0.55
vs -0.35

Q3.23

arrow
arrow

-135%

-1.35
vs -0.55

Q4.23

arrow
arrow

-2227%

-22.27
vs -1.35

Q1.24

arrow
arrow

+123%

1.23
vs -22.27

Q2.24

arrow
arrow

+6%

0.06
vs 1.23

Q3.24

arrow
arrow

-395%

-3.95
vs 0.06

Q4.24

arrow
arrow

+107%

1.07
vs -3.95

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

28

28
vs 30

-7%

Q1.23

arrow
arrow

30

30
vs 28

7%

Q2.23

arrow
arrow

32

32
vs 30

7%

Q3.23

arrow
arrow

31

31
vs 32

-3%

Q4.23

arrow
arrow

27

27
vs 31

-13%

Q1.24

arrow
arrow

26

26
vs 27

-4%

Q2.24

arrow
arrow

25

25
vs 26

-4%

Q3.24

arrow
arrow

22

22
vs 25

-12%

Earnings Growth

Latest News